TeleDIETS Addresses GLP-1 Care Gap with AI-Driven Meal Plans for Weight Loss and Chronic Disease

TeleDIETS announced new enhancements to its AI platform to support patients using GLP-1 medications such as Ozempic and Wegovy.

Ocala, FL, April 24, 2026 --(PR.com)-- Despite the rapid growth of GLP-1 prescriptions, many patients receive little to no structured nutrition guidance. TeleDIETS addresses this critical gap by delivering GLP-1-compatible meal plans designed by registered dietitians and automated through AI.

Key capabilities include:

Personalized meal plans aligned with GLP-1 therapy
Nutritional support for weight loss and metabolic health
Integration with lab-driven and diagnosis-based workflows
Automated patient engagement without manual intervention

Recent industry analysis shows that a majority of healthcare websites promoting GLP-1 therapies lack meaningful diet or exercise guidance—highlighting a major opportunity for improved care.

TeleDIETS positions itself at the intersection of:

AI healthcare technology
Food-as-Medicine initiatives
Chronic disease management

“Medication alone is not enough. Nutrition is the missing piece,” John Schirra, CEO of TeleDIETS stated.

TeleDIETS allows providers to deliver complete care models by combining medication with structured nutrition therapy—without increasing operational burden.

For partnerships and integrations, visit telediets.com.
Contact
TeleDIETS
John Schirra
661-888-4293
https://telediets.com
ContactContact
Categories